http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017119704-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_927cef905d17253d40a2e1a4dbfc8296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_764c37797762f79bedf08832dbf3a65a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C327-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-609
filingDate 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2bbea8535f5f72aef6b493a3328b16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fac05669316effe24d3e388dfb9f027a
publicationDate 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2017119704-A
titleOfInvention Positively charged water-soluble prodrug of aspirin
abstract The object of the present invention is to increase the solubility of acetylsalicylic acid in gastric juice and to allow aspirin to be transdermally administered (topical application), the permeability of aspirin through membranes and skin barriers. Is to avoid the side effects of aspirin. A novel positively charged prodrug represented by the formula (1) of acetylsalicylic acid and analogs thereof was synthesized. The positively charged amino groups of these prodrugs not only greatly increase the solubility of the drug, but also bind to the negative charge on the membrane phosphate head group, pushing the prodrug into the cytosol. The prodrug, diethylaminoethyl acetylsalicylate acetate, diffuses through human skin ˜400 times faster than acetylsalicylic acid itself and ˜100 times faster than ethyl acetylsalicylate. [Selection] Figure 2
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111508613-A
priorityDate 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3966923-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-958186-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013216670-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5513275-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5905411-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4006181-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016047841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005015994-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1180107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3365483-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467176468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466299005

Total number of triples: 30.